Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years.
The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug’s manufacturer is now presenting additional data to argue its case.
But thousands of people in San Luis Obispo County, where Qnexa’s inventor ran a weight-loss clinic, and others across the country have not had to wait for the drug’s approval. Through a regulatory loophole of sorts, many obesity doctors prescribe two separate drugs that, when taken together, are essentially the same medicine.
The widespread use of the unsanctioned combination reflects the often desperate desire for a medicine to help overcome the nation’s epidemic of obesity, doctors and patients say. Read more at nytimes.com »